Catheter Ablation: Differentiating AVNRT and AVRT Diagnoses - Cardiology

More Info

---

Understanding the nuances between Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Atrioventricular Reentrant Tachycardia (AVRT) is crucial for effective management and treatment of patients with supraventricular tachycardia (SVT). Your experience with catheter ablation and the differing diagnoses raises several important points that merit discussion.

1. Coexistence of AVNRT and AVRT: It is indeed possible for both AVNRT and AVRT to coexist in a patient. These arrhythmias can share similar clinical presentations, and the presence of multiple accessory pathways or conduction abnormalities can complicate the diagnosis. In your case, the initial diagnosis of AVNRT may have been based on the observed electrophysiological characteristics during the first catheter ablation. However, the subsequent identification of an accessory pathway during the second procedure suggests that AVRT was also a contributing factor. This duality can sometimes lead to confusion in diagnosis, especially if the arrhythmia is not consistently reproducible.

2. Empirical Ablation and Accessory Pathways: The term "empirical" in the context of your first ablation indicates that the procedure was performed based on the suspicion of an abnormal conduction pathway, even if it was not definitively identified at that time. This does not negate the possibility that the parahisian accessory pathway could have been responsible for abnormal electrical activity. The fact that the second procedure successfully identified and ablated the left lateral accessory pathway suggests that there was indeed an abnormal conduction pathway contributing to your arrhythmia.

3. Delta Waves and Diagnosis: Delta waves are typically associated with Wolff-Parkinson-White (WPW) syndrome, which is a type of AVRT. The absence of delta waves during the second procedure does not rule out AVRT; rather, it may indicate that the specific accessory pathway involved in the second episode did not manifest with delta waves on the ECG. The differing diagnoses could be attributed to the dynamic nature of your arrhythmias and the specific pathways involved during each episode. The first episode may have involved a different mechanism than the second, leading to the observed differences in ECG findings.

4. Variability in Heart Rate: The differences in heart rate during your episodes of PSVT can be attributed to several factors, including the specific pathways involved, the degree of autonomic tone, and the overall electrophysiological state of the heart at the time of the episodes. Increased heart rates can occur due to enhanced automaticity or increased conduction velocity through the pathways involved. The fact that your second episode reached a higher maximum heart rate could suggest a more efficient reentrant circuit or a different triggering mechanism.

5. VAAV Pattern and Future Risks: The VAAV pattern observed during your first ablation could indicate the presence of an accessory pathway that may not have been fully characterized at that time. While it does not necessarily predict future arrhythmias, it does warrant careful monitoring. The presence of such patterns can sometimes be associated with a higher risk of recurrent arrhythmias, especially if the underlying mechanisms are not fully understood or addressed.

In conclusion, the complexities of diagnosing and managing AVNRT and AVRT highlight the importance of thorough electrophysiological evaluation and the potential for overlapping arrhythmias. Continuous follow-up with your cardiologist and regular monitoring of your heart rhythm are essential to ensure that any future episodes are managed promptly and effectively. If you have further concerns or experience new symptoms, do not hesitate to seek additional evaluations or a second opinion from a specialist in electrophysiology.